ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 75 filers reported holding ALBIREO PHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $186,127 | +17.8% | 8,613 | +5.4% | 0.00% | 0.0% |
Q3 2022 | $158,000 | -1.2% | 8,171 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $160,000 | -36.0% | 8,055 | -3.8% | 0.00% | 0.0% |
Q1 2022 | $250,000 | +19.6% | 8,377 | -6.6% | 0.00% | 0.0% |
Q4 2021 | $209,000 | -27.4% | 8,966 | -2.9% | 0.00% | -50.0% |
Q3 2021 | $288,000 | -13.5% | 9,235 | -2.3% | 0.00% | +100.0% |
Q2 2021 | $333,000 | -4.3% | 9,454 | -4.2% | 0.00% | 0.0% |
Q1 2021 | $348,000 | -5.7% | 9,872 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $369,000 | +39.2% | 9,846 | +23.8% | 0.00% | 0.0% |
Q3 2020 | $265,000 | +23.3% | 7,953 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $215,000 | +73.4% | 8,133 | +7.7% | 0.00% | 0.0% |
Q1 2020 | $124,000 | -28.3% | 7,554 | +10.9% | 0.00% | 0.0% |
Q4 2019 | $173,000 | +26.3% | 6,814 | -0.8% | 0.00% | 0.0% |
Q3 2019 | $137,000 | -35.4% | 6,871 | +4.6% | 0.00% | 0.0% |
Q2 2019 | $212,000 | +13.4% | 6,566 | +13.1% | 0.00% | 0.0% |
Q1 2019 | $187,000 | +27.2% | 5,808 | -3.1% | 0.00% | 0.0% |
Q4 2018 | $147,000 | -26.1% | 5,996 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $199,000 | -5.7% | 6,043 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $211,000 | – | 5,935 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 198,800 | $5,266,000 | 2.26% |
Perceptive Advisors | 1,960,139 | $51,924,000 | 0.84% |
Chicago Capital, LLC | 502,212 | $13,304,000 | 0.77% |
Birchview Capital, LP | 48,000 | $1,272,000 | 0.77% |
Artal Group S.A. | 500,360 | $13,255,000 | 0.37% |
HEARTLAND ADVISORS INC | 150,000 | $3,974,000 | 0.35% |
Eversept Partners, LP | 78,029 | $2,066,988 | 0.28% |
ArrowMark Colorado Holdings LLC | 956,990 | $25,351,000 | 0.26% |
PA Capital LLC | 12,987 | $344,000 | 0.25% |
Ikarian Capital, LLC | 100,500 | $2,662,000 | 0.21% |